testing new drugs on the world's poorest patients
Examines clinical drug trials in developing countries of Africa and Asia, discussing the pharmaceutical industry's motivation to test on poor people, the treatment of patients, and ethical issues involved; and providing what the author believes to be solutions to the problem.
